Cargando…

Hematopoietic Prostaglandin D Synthase Inhibitor PK007 Decreases Muscle Necrosis in DMD mdx Model Mice

Duchenne muscular dystrophy (DMD) is characterized by progressive muscle weakness and wasting due to the lack of dystrophin protein. The acute phase of DMD is characterized by muscle necrosis and increased levels of the pro-inflammatory mediator, prostaglandin D2 (PGD2). Inhibiting the production of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yarlagadda, Sai, Kulis, Christina, Noakes, Peter G., Smythe, Mark L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469723/ https://www.ncbi.nlm.nih.gov/pubmed/34575143 http://dx.doi.org/10.3390/life11090994

Ejemplares similares

Humanizing the mdx mouse model of DMD: the long and the short of it
por: Yucel, Nora, et al.
Publicado: (2018)

Author Correction: Humanizing the mdx mouse model of DMD: the long and the short of it
por: Yucel, Nora, et al.
Publicado: (2020)

Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD
por: Mázala, Davi A. G., et al.
Publicado: (2023)

Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD
por: Mázala, Davi A. G., et al.
Publicado: (2023)

Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2013)

Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
por: Caudal, Dorian, et al.
Publicado: (2020)

Cardiovascular phenotype of the Dmd(mdx) rat – a suitable animal model for Duchenne muscular dystrophy
por: Szabó, Petra Lujza, et al.
Publicado: (2021)

Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients
por: Rossi, Rachele, et al.
Publicado: (2021)

Therapeutic Potential of Hematopoietic Prostaglandin D(2) Synthase in Allergic Inflammation
por: Rittchen, Sonja, et al.
Publicado: (2019)

“Of Mice and Measures”: A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic: First Workshop Report: Examining current findings and opportunities around the emerging D2.B10-Dmd(mdx)/J (D2/mdx) model in context of the classic C57BL/10ScSn-Dmd(mdx)/J (Bl10/mdx)
por: Gordish-Dressman, Heather, et al.
Publicado: (2018)

Improvement in the quality of hematopoietic prostaglandin D synthase crystals in a microgravity environment
por: Tanaka, Hiroaki, et al.
Publicado: (2011)

Roles of lipocalin-type and hematopoietic prostaglandin D synthases in mouse retinal angiogenesis
por: Horikami, Daiki, et al.
Publicado: (2023)

Myogenic Reprogramming of Bone Marrow Derived Cells in a W(41)Dmd(mdx) Deficient Mouse Model
por: Walsh, Stuart, et al.
Publicado: (2011)

Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse
por: Wang, Derek W., et al.
Publicado: (2018)

Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E(2)
por: Sampey, Annaleise V, et al.
Publicado: (2005)

Serotonin and Histamine Therapy Increases Tetanic Forces of Myoblasts, Reduces Muscle Injury, and Improves Grip Strength Performance of Dmd(mdx) Mice
por: Gurel, Volkan, et al.
Publicado: (2015)

Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmd(mdx)/J (D2-mdx) mice from 16–17 to 24–25 Weeks of Age
por: De Giorgio, Daria, et al.
Publicado: (2023)

Dmd(mdx)/Large(myd): a new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies
por: Martins, Poliana C. M., et al.
Publicado: (2013)

Decrease in Prosaposin in the Dystrophic mdx Mouse Brain
por: Gao, Hui-ling, et al.
Publicado: (2013)

Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology
por: Farhat, Andalib, et al.
Publicado: (2011)

Inhibition of hematopoietic prostaglandin D(2) Synthase (H-PGDS) by an alkaloid extract from Combretum molle
por: Moyo, Rejoice, et al.
Publicado: (2014)

Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
por: Heemskerk, Hans, et al.
Publicado: (2010)

Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E(2) synthesis in vitro and ameliorates experimental periodontitis in vivo
por: Kats, Anna, et al.
Publicado: (2013)

DMD & BMD – CLINICAL: P.51 DMD Hub: demonstrating impact for DMD trials
por: Heslop, E., et al.
Publicado: (2020)

Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin-Deficient D2.B10-Dmd(mdx)/J Mouse
por: Hayes, Holly M., et al.
Publicado: (2022)

In situ imaging reveals disparity between prostaglandin localization and abundance of prostaglandin synthases
por: Duncan, Kyle D., et al.
Publicado: (2021)

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
por: Wehling, Michelle, et al.
Publicado: (2001)

Lipocalin-Like Prostaglandin D Synthase but Not Hemopoietic Prostaglandin D Synthase Deletion Causes Hypertension and Accelerates Thrombogenesis in Mice
por: Song, Wen-Liang, et al.
Publicado: (2018)

Metabolism of aromatic amines by prostaglandin H synthase.
por: Boyd, J A, et al.
Publicado: (1985)

Prostaglandin terminal synthases as novel therapeutic targets
por: HARA, Shuntaro
Publicado: (2017)

Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype
por: Smythe, Gayle M, et al.
Publicado: (2012)

Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients
por: Vitiello, Libero, et al.
Publicado: (2018)

Alterations in the expression of leukemia inhibitory factor following exercise: comparisons between wild-type and mdx muscles
por: Hunt, Liam C, et al.
Publicado: (2011)

P007 Eating in alignment with the circadian clock: A strategy to reduce the metabolic impact of nightwork
por: Centofanti, S, et al.
Publicado: (2021)

Decreasing microtubule detyrosination by parthenolide restores sodium current in mdx cardiomyocytes
por: Casini, S, et al.
Publicado: (2023)

Sulforaphane Inhibits Prostaglandin E2 Synthesis by Suppressing Microsomal Prostaglandin E Synthase 1
por: Zhou, Jiping, et al.
Publicado: (2012)

Author Correction: In situ imaging reveals disparity between prostaglandin localization and abundance of prostaglandin synthases
por: Duncan, Kyle D., et al.
Publicado: (2021)

Upregulation of prostaglandin E(2) by inducible microsomal prostaglandin E synthase-1 in colon cancer
por: Kim, Young Hun, et al.
Publicado: (2022)

Rapid degradation of cyclooxygenase-1 and hematopoietic prostaglandin D synthase through ubiquitin–proteasome system in response to intracellular calcium level
por: Yazaki, Misato, et al.
Publicado: (2012)

Microsomal Prostaglandin E Synthase-1 in Rheumatic Diseases
por: Korotkova, Marina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ltv6rli9oqkbcciqi0c325i5h1